131 related articles for article (PubMed ID: 38342608)
1. Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype.
Enbergs N; Halabi EA; Goubet AG; Schleyer K; Fredrich IR; Kohler RH; Garris CS; Pittet MJ; Weissleder R
Adv Sci (Weinh); 2024 Apr; 11(15):e2309026. PubMed ID: 38342608
[TBL] [Abstract][Full Text] [Related]
2. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8
Luan X; Lei T; Fang J; Liu X; Fu H; Li Y; Chu W; Jiang P; Tong C; Qi H; Fu Y
Mol Ther; 2024 Feb; 32(2):469-489. PubMed ID: 38098230
[TBL] [Abstract][Full Text] [Related]
3. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
Marcovecchio PM; Thomas G; Salek-Ardakani S
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637602
[TBL] [Abstract][Full Text] [Related]
4. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
[TBL] [Abstract][Full Text] [Related]
5. Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators.
Su X; Liang C; Chen R; Duan S
Mol Cancer; 2024 Jan; 23(1):13. PubMed ID: 38217023
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
7. Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment.
Qu Y; Wen J; Thomas G; Yang W; Prior W; He W; Sundar P; Wang X; Potluri S; Salek-Ardakani S
Cell Rep; 2020 Jul; 32(1):107873. PubMed ID: 32640238
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory Phenotype.
Nishida-Aoki N; Gujral TS
Cancer Res; 2022 Feb; 82(3):433-446. PubMed ID: 34903600
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
10. Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
Tigue ML; Loberg MA; Goettel JA; Weiss WA; Lee E; Weiss VL
Cancer Res; 2023 Jan; 83(1):3-11. PubMed ID: 36214645
[TBL] [Abstract][Full Text] [Related]
11. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
12. Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions.
Ortega RA; Barham W; Sharman K; Tikhomirov O; Giorgio TD; Yull FE
Int J Nanomedicine; 2016; 11():2163-77. PubMed ID: 27274241
[TBL] [Abstract][Full Text] [Related]
13. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach.
Chamseddine AN; Assi T; Mir O; Chouaib S
Pharmacol Ther; 2022 Mar; 231():107986. PubMed ID: 34481812
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the CXCL9-CXCR3 axis suppresses the progression of experimental apical periodontitis by blocking macrophage migration and activation.
Hasegawa T; Venkata Suresh V; Yahata Y; Nakano M; Suzuki S; Suzuki S; Yamada S; Kitaura H; Mizoguchi I; Noiri Y; Handa K; Saito M
Sci Rep; 2021 Jan; 11(1):2613. PubMed ID: 33510341
[TBL] [Abstract][Full Text] [Related]
15. C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
Magnusen AF; Rani R; McKay MA; Hatton SL; Nyamajenjere TC; Magnusen DNA; Köhl J; Grabowski GA; Pandey MK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884512
[TBL] [Abstract][Full Text] [Related]
16. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Wang T; Zhang J; Hou T; Yin X; Zhang N
Nanoscale; 2019 Aug; 11(29):13934-13946. PubMed ID: 31305839
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications.
P Vassilakopoulos T; Levidou G; Milionis V; Hartmann S; Lakiotaki E; Sepsa A; Thymara I; Ntailiani P; Spanou K; K Angelopoulou M; P Siakantaris M; Moschogiannis M; A Pangalis G; Panayiotidis P; Konstantopoulos K; Patsouris E; Hansmann ML; Korkolopoulou P
Leuk Lymphoma; 2017 Sep; 58(9):1-13. PubMed ID: 28571489
[TBL] [Abstract][Full Text] [Related]
18. Targeting macrophages: a novel avenue for cancer drug discovery.
Kumar S; Ramesh A; Kulkarni A
Expert Opin Drug Discov; 2020 May; 15(5):561-574. PubMed ID: 32141351
[No Abstract] [Full Text] [Related]
19. Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment.
Reichel D; Tripathi M; Perez JM
Nanotheranostics; 2019; 3(1):66-88. PubMed ID: 30662824
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages.
Sun JL; Zhang NP; Xu RC; Zhang GC; Liu ZY; Abuduwaili W; Wang F; Yu XN; Shi X; Song GQ; Wu H; Liu TT; Shen XZ; Deng B; Weng SQ; Dong L; Zhu JM
J Transl Med; 2021 Aug; 19(1):347. PubMed ID: 34389031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
